Department of Pediatric Internal Medicine, Linyi Central Hospital, Linyi, China.
Eur Rev Med Pharmacol Sci. 2020 May;24(9):4931-4939. doi: 10.26355/eurrev_202005_21182.
Previous studies have shown that glycosylphosphatidylinositol Anchor Attachment Protein 1 (GPAA1) is a cancer-promoting gene; however, the role of GPAA1 in childhood acute lymphoblastic leukemia (ALL) has not been reported. This study aims to illustrate the role of GPAA1 in promoting the metastasis of ALL by targeting c-myc and the potential mechanism.
Quantitative real time-polymerase chain reaction (qRT-PCR) was performed to examine serum levels of GPAA1 and c-myc in 42 childhood ALL patients and healthy volunteers. The interaction between GPAA1 expression and prognosis of childhood ALL was analyzed. Meanwhile, expressions of GPAA1 and c-myc in ALL cell lines were determined by qRT-PCR. Furthermore, after GPAA1 knockdown model was constructed by lentivirus transfection in MOLT-4 and SUP-B15 cells, cell counting kit-8 (CCK-8), transwell invasion, and cell wound healing assays were conducted to analyze the effect of GPAA1 on the biological functions of ALL cells. Potential mechanism was further explored through Luciferase reporter gene assay and cell recovery experiments.
QRT-PCR results indicated that serum level of GPAA1 in childhood ALL patients was remarkably higher than that of healthy volunteers, and the difference was statistically significant. Childhood ALL patients with high expression of GPAA1 had lower overall survival rate compared with those expressing low expression of GPAA1. Proliferation and metastasis abilities of pediatric ALL cells with GPAA1 knockdown remarkably decreased. Subsequently, c-myc expression was also found remarkably upregulated in ALL cell lines and serum samples of childhood ALL patients and it was positively correlated with GPAA1 level. In addition, Luciferase reporter gene assay demonstrated that overexpression of c-myc remarkably attenuated the Luciferase activity of the wild-type GPAA1 vector without attenuating that of the mutant vector or empty vector, further demonstrating that GPAA1 can be targeted by c-myc. At the same time, cell recovery experiment found that the interaction between GPAA1 and c-myc together regulated the malignant progression of ALL.
GPAA1 was up-regulated in serum of childhood ALL patients, which was remarkably associated with the prognosis. In addition, GPAA1 may contribute to the malignant progression of childhood ALL via activating c-myc.
先前的研究表明糖基磷脂酰肌醇锚定连接蛋白 1(GPAA1)是一种促进癌症的基因;然而,GPAA1 在儿童急性淋巴细胞白血病(ALL)中的作用尚未被报道。本研究旨在通过靶向 c-myc 阐明 GPAA1 在促进 ALL 转移中的作用及其潜在机制。
采用实时定量聚合酶链反应(qRT-PCR)检测 42 例儿童 ALL 患者和健康志愿者血清中 GPAA1 和 c-myc 的水平。分析 GPAA1 表达与儿童 ALL 预后的关系。同时,采用 qRT-PCR 检测 ALL 细胞系中 GPAA1 和 c-myc 的表达。进一步构建 MOLT-4 和 SUP-B15 细胞的 GPAA1 敲低模型,通过细胞计数试剂盒-8(CCK-8)、Transwell 侵袭和细胞划痕愈合实验分析 GPAA1 对 ALL 细胞生物学功能的影响。通过荧光素酶报告基因检测和细胞恢复实验进一步探讨潜在机制。
qRT-PCR 结果表明,儿童 ALL 患者血清中 GPAA1 水平明显高于健康志愿者,差异有统计学意义。GPAA1 高表达的儿童 ALL 患者总生存率明显低于低表达患者。GPAA1 敲低后儿科 ALL 细胞的增殖和转移能力明显下降。随后,发现 ALL 细胞系和儿童 ALL 患者血清样本中 c-myc 的表达也明显上调,且与 GPAA1 水平呈正相关。此外,荧光素酶报告基因检测表明,c-myc 的过表达显著减弱野生型 GPAA1 载体的荧光素酶活性,而不减弱突变型载体或空载体的荧光素酶活性,进一步证明 GPAA1 可以被 c-myc 靶向。同时,细胞恢复实验发现,GPAA1 和 c-myc 之间的相互作用共同调节 ALL 的恶性进展。
GPAA1 在儿童 ALL 患者血清中上调,与预后显著相关。此外,GPAA1 可能通过激活 c-myc 促进儿童 ALL 的恶性进展。